If setting up a gliptin which has a sulfonylurea, minimizing the dose of either drug can be required to minimise the potential risk of hypoglycaemia (see Dosing concerns).System fat considerably influences the pharmacokinetics of liraglutide depending on success of population pharmacokinetic analyses executed in patients with human body weight vari